EUVIMEDEUVIMED entdecken
Crossref

A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen

Marco M Z Sharkawi, Noha H Amin, Norhan R Mohamed, Loah R Hemeda, Shimaa S Zaki

Analytica Chimica Acta · 2026-08 · 1411 · 345652

DOI: 10.1016/j.aca.2026.345652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-08. Verfasst von Marco M Z Sharkawi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Alshaheed Shehata Ahmed Hegazy St., Beni-Suef, 62514, Egyp…. Hauptthemen laut MEDLINE: Dexamethasone, Bendamustine Hydrochloride, Bortezomib, Antineoplastic Agents. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a hematological malignancy associated with high morbidity and mortality. The BBD salvage regimen, consisting of bendamustine (BEN), bortezomib (BOR), and dexamethasone (DEX), has demonstrated efficacy in patients with relapsed or refractory MM. However, no analytical method has been reported for the simultaneous determination of this regimen, and potential pharmacokinetic interactions among its components remain insufficiently explored. In this study, two environmentally friendly, sensitive, and rapid chromatographic methods were developed and validated for the simultaneous quantification of BEN, BOR, and DEX in rat plasma, using sildenafil (SIL) as an internal standard. The methods showed linearity over wide concentration ranges, along with satisfactory accuracy and precision, and were successfully applied to in vivo pharmacokinetic studies following individual and combined administration of the three drugs. The results revealed measurable changes in pharmacokinetic parameters, suggesting potential pharmacokinetic interactions among the components of the BBD regimen. The LC-MS/MS method provided higher sensitivity and selectivity, while the TLC-densitometric method offered a simpler and more environmentally friendly alternative for routine analysis. In addition, the environmental sustainability of the proposed methods was evaluated using multiple greenness assessment tools, confirming their eco-friendly profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneBendamustine HydrochlorideBortezomibAntineoplastic AgentsGreen Chemistry TechnologyAnimalsRatsTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

BendamustineBortezomibChromatographic methodsDexamethasoneGreen chemistryPharmacokinetics

Substanzen

DexamethasoneBendamustine HydrochlorideBortezomibAntineoplastic Agents

Autor:innen und Institutionen

  • Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Alshaheed Shehata Ahmed Hegazy St., Beni-Suef, 62514, Egypt. Electronic address: marcomounir11@yahoo.com.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: norhan.rafat@yahoo.com.

Zitieren

APA

Sharkawi, M. M. Z., Amin, N. H., Mohamed, N. R., Hemeda, L. R., & Zaki, S. S. (2026). A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen. Analytica Chimica Acta, 1411, 345652. https://doi.org/10.1016/j.aca.2026.345652

Vancouver

Sharkawi MMZ, Amin NH, Mohamed NR, Hemeda LR, Zaki SS. A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen. Analytica Chimica Acta. 2026;1411:345652. doi:10.1016/j.aca.2026.345652

BibTeX
@article{Sharkawi2026,
  author = {Sharkawi, Marco M Z and Amin, Noha H and Mohamed, Norhan R and Hemeda, Loah R and Zaki, Shimaa S},
  title = {A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen},
  journal = {Analytica Chimica Acta},
  year = {2026},
  volume = {1411},
  pages = {345652},
  doi = {10.1016/j.aca.2026.345652}
}
Kostenlos starten →